Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin
about
Medicinal Plants and Their Inhibitory Activities against Pancreatic Lipase: A ReviewOperon for biosynthesis of lipstatin, the Beta-lactone inhibitor of human pancreatic lipaseTetrahydrolipstatin inhibition, functional analyses, and three-dimensional structure of a lipase essential for mycobacterial viabilityImproving palm oil quality through identification and mapping of the lipase gene causing oil deteriorationThe lipase C-terminal domain. A novel unusual inhibitor of pancreatic lipase activity.Chemical screen to reduce sterol accumulation in Niemann-Pick C disease cells identifies novel lysosomal acid lipase inhibitors.Development of a novel, cell-based chemical screen to identify inhibitors of intraphagosomal lipolysis in macrophages.Acute lipotoxicity regulates severity of biliary acute pancreatitis without affecting its initiationSleep-disordered breathing and obesity: pathophysiology, complications, and treatmentBiochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker.Review of limited systemic absorption of orlistat, a lipase inhibitor, in healthy human volunteers.Protein-reactive natural products.Orlistat: in the prevention and treatment of type 2 diabetes mellitus.Each lipase has a unique sensitivity profile for organophosphorus inhibitors.The use of serotonergic drugs to treat obesity--is there any hope?The metabolic serine hydrolases and their functions in mammalian physiology and disease.The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans.Role of lipase in the regulation of postprandial gastric acid secretion and emptying of fat in humans: a study with orlistat, a highly specific lipase inhibitorModulation of the Activity of Mycobacterium tuberculosis LipY by Its PE DomainLong-term pharmacotherapy for obesity.Glucose homeostasis and the gastrointestinal tract: insights into the treatment of diabetes.Beyond triglyceride synthesis: the dynamic functional roles of MGAT and DGAT enzymes in energy metabolismRT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models.Reversible lipid accumulation and associated division arrest of Mycobacterium avium in lipoprotein-induced foamy macrophages may resemble key events during latency and reactivation of tuberculosisNatural products and their biological targets: proteomic and metabolomic labeling strategies.Elimination of persistent toxicants from the human body.Effects of surfactants on lipase structure, activity, and inhibition.Lipolytic proteomics.A natural solution for obesity: bioactives for the prevention and treatment of weight gain. A review.The role of seaweed bioactives in the control of digestion: implications for obesity treatments.Fatty Acids and Breast Cancer: Make Them on Site or Have Them Delivered.The properties of the mucus barrier, a unique gel--how can nanoparticles cross it?Inhibitory effects of tunisian marine algal extracts on digestive lipases.Ceramicine B, a limonoid with anti-lipid droplets accumulation activity from Chisocheton ceramicus.Synthesis and biological investigation of the β-thiolactone and β-lactam analogs of tetrahydrolipstatin.The modulation of pancreatic lipase activity by alginates.Hydrolysis of tumor cell lipids after CTL-mediated death.A broad pH range indicator-based spectrophotometric assay for true lipases using tributyrin and tricaprylin.Role of lipase in Burkholderia cepacia complex (Bcc) invasion of lung epithelial cells.Biological activity of alginate and its effect on pancreatic lipase inhibition as a potential treatment for obesity.
P2860
Q26774088-26B228AD-4A2C-4C4F-A6C2-F00872A48A68Q28248341-0CF61BCC-A0E4-405B-A6F4-180CAC17A7A1Q28487544-BE7FEA40-0ADC-4B4E-8DC6-4DC2F7F38CC3Q28676966-69B56FC3-D4E4-4EEB-AFFD-6E1AD74CACEFQ30648549-6084A80A-87E8-4A33-9017-0A7DEA7E039EQ30872586-76DCC9C6-0D78-4544-94F4-24D75CA96655Q33638744-D7C6E995-C56A-49BF-945F-19FD39E2DE6BQ33708690-4B7BE580-7153-4E0E-A2C5-FC705BAAFFFCQ33863155-C464BEA4-E584-4575-9D8E-755A9B63BFACQ34058540-10DE5927-8EFD-4A8E-BDE3-23555ABC20C6Q34379128-D2ABE412-665B-4698-A47E-2F18EF8B241BQ34449212-5A5A291E-9EF9-4E5F-A41F-478326D55020Q34458506-E94BEF0B-F006-4578-938D-55CCF0F7DFE2Q34490085-67ADF7C8-6CD2-43B4-BECB-9447BF580389Q34712327-BE96C207-03CB-41F9-8788-2590A24FD612Q35333042-B68E9E7A-718F-4452-8DAA-C4500B64A478Q35359964-AC3DE6B3-954F-4107-9E5E-C48EBE27E607Q35557602-C66818F4-2562-4A4C-8CDE-3D5DA5C34485Q35745007-3EE2D4A8-559F-4DAE-8449-754B61D73D53Q36027626-2430FE06-F830-4EFE-912A-905E5FC2CC89Q36816194-C781FD89-66D7-466E-9A1D-503CCE1CAA8BQ37076454-D4F23918-201B-4737-9081-39902D60BD88Q37428359-963791C6-A1ED-4B45-A557-996E259C1FDCQ37546501-3754D54E-FA45-4DD6-B793-025171B9A41DQ37718098-24BF1D05-2E70-48B5-85BA-0CAA3EA371BBQ37733171-115A7D70-868C-4A31-8456-96F6C03C56D5Q37828446-28FA9AE3-B7A4-4984-9B6A-1DD48313D015Q37990875-A4327FBE-6307-4F58-B149-661858C7B475Q38195322-10D11D86-1897-40F1-9BC6-1EF5FAF69478Q38594928-81CF2863-C2BB-4B15-9FBC-7F874704A820Q38722530-CCDA4CFD-6575-4FB2-96AD-71104583120EQ38787318-48939282-752F-4DD0-8EAE-2E23B7735C94Q38902386-BE67FC56-BD3E-485C-B813-B4CB73A5B564Q39180911-BEFF8589-5FF9-4F73-9215-4C186A90A8A6Q39392568-072A0A4E-8E80-4DBD-8287-8A246818DC19Q39532632-F6E3C650-048A-439D-8C73-4CE02063F372Q39867671-6833AC08-C725-4C70-84AF-E9AC0EAF08A7Q39945424-90E3FCDF-8BAC-4BB0-88B6-5D39EF97B59CQ40079704-E9997FDF-BF22-41A5-90BF-8075D91A1958Q40617799-E000615C-77E9-4EE7-A0DB-5827E215F796
P2860
Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin
@en
type
label
Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin
@en
prefLabel
Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin
@en
P2093
P2860
P356
P1433
P1476
Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin
@en
P2093
P2860
P304
P356
10.1042/BJ2560357
P407
P577
1988-12-01T00:00:00Z